Hypothesis

In cognitively normal aging, neuronal METTL3/METTL14 activity increases, leading to elevated m6A deposition preferentially in the 3'UTRs of synaptic and proteostasis genes. This modification recruits IGF2BP2, which not only stabilizes transcripts but also interferes with upstream nonsense-mediated decay (NMD) by blocking exon junction complex (EJC) assembly downstream of stop codons. Consequently, m6A-modified proteostasis mRNAs (e.g., HSP70, BAG3, ATG5, PSMB5) evade NMD-mediated degradation, maintaining protein quality control despite age-related stress. In Alzheimer's disease, the age-associated m6A increase fails, resulting in loss of IGF2BP2 binding, restored NMD activity, and selective depletion of proteostasis transcripts, thereby linking m6A loss to proteolytic dysfunction. Premature aging models show decreased METTL3 and global m6A loss, which similarly elevates NMD of proteostasis mRNAs, explaining their early-onset aggregation phenotypes.

Testable Predictions

1. 'm6A‑NMD competition': In young neurons, inhibiting IGF2BP2 (siRNA or CRISPRi) will increase NMD susceptibility of m6A‑modified proteostasis transcripts, measurable by increased upstream open reading frame (uORF)‑derived isoforms and reduced mRNA half‑life, without affecting total m6A levels.
2. 'Rescue of proteostasis': Overexpressing a catalytically dead METTL3 that retains RNA‑binding but cannot methylate will not rescue NMD suppression, indicating that the methyl group itself is required for IGF2BP2‑mediated NMD inhibition.
3. 'Disease specificity': AD‑derived iPSC neurons will show

Hypothesis

The order in which selective autophagy receptors (SARs) engage their cargo is not fixed by receptor abundance alone; instead, it is tuned by micro‑domains of acetyl‑CoA that accumulate at the surface of mitochondria, ER, lysosomes, and peroxisomes. High local acetyl‑CoA acetylates lysine residues on SARs or their adaptor proteins, altering binding affinity for ubiquitin tags and thereby shifting the pecking order of organelle turnover. With age, declining mitochondrial output and altered nucleocytoplasmic transport reduce acetyl‑CoA synthesis at specific organelles, flattening the gradient and causing a mis‑prioritization that leads to selective accumulation of damaged cargoes (e.g., depolarized mitochondria in neurons, ER stress in hepatocytes). This model predicts that restoring organelle‑specific acetyl‑CoA levels will rescue selective autophagy flux without changing global autophagy rates.

Mechanistic Basis

1. Acetyl‑CoA as a post‑translational modifier – Acetyl‑CoA can donate acetyl groups to lysine residues via non‑enzymatic acetylation or via acetyltransferases that are recruited to organelles (e.g., ATAT1 at mitochondria). Acetylation of SARs such as FAM134B (ER‑phagy) or BNIP3 (mitophagy) has been shown to modulate their interaction with LC3 and ubiquitin chains (local acetyl-CoA blocks ER‑phagy).
2. Spatial compartmentalization – Mitochondrial citrate exported via SLC25A1 and cleaved by ACLY generates a cytosolic acetyl‑CoA pool that can be further channeled into organelles by ACSS2 o

Hypothesis

Aged stem cells lose specific long-range enhancer-promoter contacts at super-enhancers that maintain anti-inflammatory transcriptional programs. This contact loss, rather than mere reduction of H3K27ac, precipitates a shift toward pro-inflammatory states and functional decline. Stabilizing these contacts through cohesin enrichment will restore anti-inflammatory gene expression and improve stem cell activity.

Background

• Aging remodels H3K27ac at enhancers and induces inflammatory responses across tissues [1].
• Muscle satellite cells show dynamic H3K4me3 retention and H3K27me3 gain during activation, indicating chromatin state transitions are behaviorally relevant [2].
• Current data describe mark changes but have not directly measured 3D enhancer-promoter architecture in aged stem cells.

Mechanistic Insight

Super-enhancers drive high transcriptional output via phase‑separated hubs that depend on cohesin‑mediated loop extrusion. With age, reduced H3K27ac may weaken Mediator and coactivator binding, diminishing the stability of these hubs. Consequently, cohesin fails to sustain persistent loops, leading to contact erosion. The loss of contacts specifically attenuates looping to promoters of anti‑inflammatory genes (e.g., Il10, Tgfb1) while permitting aberrant contacts to pro‑inflammatory loci, thereby biasing transcription without requiring new enhancer activation.

Testable Predictions

1. Contact decay: HiChIP for H3K27ac and RAD21 (cohesin) will reveal significantly reduced loop frequency at super‑enhancers linked to anti‑inflammatory genes in

Hypothesis\n\nAging disrupts the intestinal Wnt morphogen gradient not only by lowering Wnt3 ligand and raising Notum from Paneth cells, but also by depriving the niche of microbiota‑derived short‑chain fatty acids (SCFAs) that normally restrain Notum secretion via GPR43‑mediated signaling. We propose that restoring SCFA production—either through supplementation with SCFA‑producing strains (e.g., Faecalibacterium prausnitzii) or direct acetate/propionate administration—will inhibit Paneth cell Notum expression, thereby allowing Wnt3 to re‑establish a steep crypt‑villus gradient. Concurrently, NAD⁺‑precursor‑driven SIRT1 activation stabilizes β‑catenin, amplifying Wnt transcriptional output and creating a positive feedback loop that further suppresses Notum. This combined metabolic‑microbiome‑Wnt axis resets gradient topology, expands functional crypt number, and rejuvenates ISC regenerative capacity without provoking tumorigenic Wnt hyperactivity because SCFA‑SIRT1 signaling also engages APC‑dependent β‑catenin degradation controls.\n\n### Testable Predictions\n\n1. Spatial rescue – In aged mice, oral gavage with acetate (150 mM) or a defined SCFA‑producing consortium will increase Wnt3 ligand signal at the crypt base and decrease Notum staining, measurable by multiplexed spatial transcriptomics (e.g., 10x Visium) within 7 days.\n2. Functional readout – The same treatment will raise Lgr5⁺ ISC frequency, organoid forming efficiency, and recovery after irradiation injury, comparable to Wnt3a supplementation or Notum inhibition.\n3. Mechanistic dependence – Ge

Hypothesis

Engineered AAV capsids with strong skeletal muscle tropism and minimal liver uptake can deliver a mitochondrially targeted senolytic peptide (e.g., a BCL‑XL inhibitor fused to a mitochondrial targeting sequence) to post‑mitotic myonuclei, achieving long‑term expression that reduces senescent cell burden and mitochondrial ROS in muscle. The resulting improvement in muscle mitochondrial function triggers secretion of mitokines such as FGF21 and GDF15, which act systemically to improve metabolic health, reduce inflammation, and extend lifespan in aging mice.

Rationale

• Recent advances show AAV9 crosses the BBB and AAVrh.74 leads in cardiac transduction, while AAV4 exhibits pan‑endothelial tropism via sialic acid binding independent of AAVR [1] [2].
• AI‑driven platforms like AAVGen can now simultaneously optimize capsid features for kidney tropism, thermostability, and manufacturability [3].
• Despite these capabilities, longevity applications remain unexplored; no clinical trials have tested AAV delivery of telomerase, Yamanaka factors, senolytics, or mitochondrial genes [1] [4].
• Skeletal muscle is a post‑mitotic, long‑lived tissue that can act as a secretory

Hypothesis: Age‑related loss of motor innervation to the thyroarytenoid (TA) muscle creates a chronic unloading state that shifts vocal‑fold fibroblasts toward a pathogenic myofibroblast phenotype, thereby accelerating lamina propria extracellular‑matrix (ECM) breakdown. This mechanotransduction cascade positions TA denervation as the upstream event that drives both sarcopenic atrophy and ECM remodeling, whereas preserved innervation maintains ECM integrity independent of muscle bulk TA atrophy primary driver ECM changes secondary.

To test this, we will (1) induce selective denervation of the TA in young adult sheep via botulinum toxin‑mediated chemoneurotraction or surgical nerve cut, (2) quantify TA cross‑sectional area, fiber‑type distribution, and innervation status using immunohistochemistry and electrophysiology at 4, 8, and 12 weeks, (3) simultaneously measure lamina propria ECM metrics—collagen fibril organization (second‑harmonic generation imaging), elastin content (Verhoeff stain), and hyaluronic acid concentration (ELISA)—and compute effect sizes (Cohen’s d) versus sham‑operated controls, (4) assess fibroblast phenotype by single‑cell RNA‑seq for activation markers (ACTA2, COL1A1, TGFB1) and myofibroblast signature, and (5) rescue a subset with chronic functional electrical stimulation (FES) or neurotrophic factor (GDNF) delivery to re‑establish innervation. If denervation precedes and predicts ECM degradation (significant regression β > 

Hypothesis

Young‑onset CRC arises from focal, transient epigenetic shocks in the distal colon triggered by diet‑microbiome interactions that overwhelm local mismatch repair, whereas late‑onset CRC stems from a diffuse, age‑dependent decline in mismatch repair proteins across the whole colon, producing a broad field of epigenetically altered crypts.

Mechanistic Basis

• In individuals <50 y, high‑fat, low‑fiber diets promote a mucosal microbiome enriched in bile‑acid‑tolerant anaerobes (e.g., Bilophila wadsworthia) that generate reactive oxygen species and inhibit DNA methyltransferase activity at specific CpG shores, producing sharp, focal hyper‑methylation of tumor suppressor promoters (e.g., SFRP2, MGMT) within 2‑5 crypt units.
• This focal shock creates a transient mismatch repair deficit limited to the affected crypt clusters, sufficient to initiate mutagenesis but not to sustain a widespread field.
• With advancing age, cumulative oxidative stress and inflammaging drive a gradual, colon‑wide reduction in MMR protein expression (PMS2, MLH1) via epigenetic silencing of their promoters and impaired proteostasis, resulting in a diffuse field cancerization where methylation frequencies exceed 50 % for markers such as SFRP2 up to 10 cm from any lesion.
• Consequently, the epigenetic landscape of normal‑appearing mucosa differs: young‑onset shows patchy, high‑amplitude methylation peaks; late‑onset exhibits low‑grade, uniform methylation across large distances.

Testable Predictions

1. Bisulfite sequencing of normal mucosa from patients <50 y will reveal m

Intermittent fasting (IF) raises intracellular NAD+ levels, activating SIRT1, which deacetylates the NF‑κB p65 subunit. This reduces NF‑κB transcriptional activity, attenuates NLRP3 inflammasome priming, and permits SIRT1‑dependent deacetylation of histones at exhaustion loci (TOX, NR4A), thereby resetting chromatin to a less repressed state and restoring cytotoxic function in aged CD8+ T cells.

Rationale

• The NF‑κB/NLRP3 circuit sustains IL‑6/TNF‑α production and drives T‑cell exhaustion through checkpoint upregulation and metabolic dysfunction【NF‑κB primes NLRP3 inflammasome activation】.
• NIK deficiency in CD8+ T cells increases PD‑1/Tim3 expression and apoptosis, indicating basal NF‑κB activity is required to prevent terminal exhaustion【NIK deficiency increases PD1/Tim3】.
• p62/SQSTM1 promotes mitophagy to restrain NLRP3; its loss worsens IL‑1β inflammation【p62 induces mitophagy】.
• NAD+/SIRT1 signaling is known to deacetylate p65, suppressing NF‑κB‑driven transcription【SIRT1 deacetylates p65】.
• SIRT1 also deacetylates histone H3K9ac at promoters of exhaustion‑associated genes, facilitating a more open chromatin state【SIRT1 chromatin remodeling】.

Hypothesis

Emodin selectively eliminates senescent cells that have arisen from circadian disruption by inhibiting MAPK signaling, which in turn stabilizes the BMAL1 protein and reinstates circadian transcriptional repression of senescence‑associated programs.

Rationale

Circadian loss‑of‑function (e.g., BMAL1 or CLOCK knockdown) hyperactivates MAPK/ERK pathways, driving p16^INK4a^/p21^CIP1^ expression and senescence [1]. Senescent cells that emerge under this condition become dependent on sustained MAPK signaling for survival [2]. Emodin is a potent inhibitor of EGFR‑mediated MAPK/ERK signaling [3] and can induce apoptosis via caspase‑3 activation [4]; however, its selectivity for senescent versus proliferating cells remains untested. Notably, ERK‑mediated phosphorylation of BMAL1 targets it for proteasomal degradation [5]; thus, MAPK inhibition by emodin could prevent BMAL1 turnover, enhancing its nuclear accumulation and transcriptional activity. Restored BMAL1 would then repress AP‑1‑driven senescence effectors and re‑establish circadian gating of autophagy and DNA‑damage response, creating a dual senolytic/circadian‑restorative mechanism.

Predictions

1. In cells with circadian disruption (e.g., Bmal1 siRNA or chronic jet‑lag regimen), emodin will reduce viability more strongly than in circadian‑intact controls.

Hypothesis Aged stromal cells secrete exosomes enriched in miR-21-5p and miR-155-3p that are taken up by nearby T cells and macrophages, where they suppress ULK1 and ATG5 expression and concomitantly activate PI3K/Akt/mTORC1 signaling. This paracrine inhibition of autophagy leads to mitochondrial ROS accumulation, NLRP3 inflammasome priming, and a feed‑forward loop that sustains inflammaging. Blocking EV release or neutralizing these miRNAs restores autophagic flux and reduces inflammatory output even in an aged microenvironment.

Mechanistic rationale

• Immunosenescence is characterized by defective autophagy in lymphocytes and myeloid cells, yet core autophagy proteins remain expressed [1].
• Extracellular vesicles (EVs) from old serum carry a distinct miRNA repertoire that alters recipient cell phenotype [2].
• miR-21-5p targets PTEN, leading to Akt activation and mTORC1 up‑regulation [3].
• miR-155-3p directly binds the 3′‑UTR of ULK1, impairing its translation [4].
• Combined, these EV‑derived miRNAs create a dual hit: translational blockade of autophagy initiators and hyperactive mTORC1, reproducing the active suppression described in aged fibroblasts.

Testable predictions

• EVs from old serum show elevated levels of miR-21-5p and miR-155-3p compared with young serum (quantified by qPCR after ultracentrifugation or size‑exclusion chromatography).
• Incubation of naïve young

Hypothesis: mTOR Hyperactivation Induces Splicing Factor Stoichiometric Imbalance, Driving Transcriptomic Entropy and Metabolic Dysregulation

Core Idea

When mTORC1 activity exceeds a physiologic threshold, it not only promotes growth but also dysregulates the expression and splicing of splicing factor genes (e.g., SRSF1/3/7), altering their relative abundances. This perturbs the spliceosome's composition, leading to widespread isoform switching that decouples transcriptome from metabolome—what we term splicing entropy.

Testable Predictions

• Prediction 1: Graded overexpression of DEPTOR will create a biphasic response: low DEPTOR (high mTOR) increases splicing noise, measured as increased intron retention and exon skipping variance across biological replicates; moderate DEPTOR restores fidelity; high DEPTOR (low mTOR) reduces noise but also lowers biosynthetic output.
• Prediction 2: Genes whose splicing is mTOR‑dependent (the 409 nutrient‑responsive set) will show the greatest increase in isoform variance under mTOR hyperactivation, and their corresponding metabolite levels will become discordant with isoform abundance.
• Prediction 3: Pharmacologic rescue of splicing factor stoichiometry (e.g., inducible expression of a balanced SRSF1/3/7 cocktail) will mitigate the metabolic dysregulation caused by mTOR hyperactivation without altering mTOR signaling per se.

Experimental Approach

1. Generate a doxycycline‑inducible DEPTOR titration series in human fibroblasts.
2. Treat cells with a range of doxycycline concentrations to achieve low, mediu

Hypothesis

Age‑associated mitochondrial dysfunction increases ROS production in dermal fibroblasts and chondrocytes, which activates DNMT3A‑mediated methylation of the HAS2 promoter. This epigenetic repression reduces HMW‑HA synthesis, shifts the HA fragment spectrum toward LMW‑HA (100–400 kDa), and amplifies TLR2/4‑NF‑κB signaling locally and systemically. Restoring mitochondrial NAD⁺ levels with nicotinamide riboside (NR) will reduce ROS, diminish DNMT3A activity, reactivate HAS2 expression, and lower circulating LMW‑HA, thereby attenuating both skin inflammation and joint osteoarthritis.

Rationale

• et al. show that HAS2 downregulation in aging dermis and joints correlates with LMW‑HA‑driven TLR2/4 activation and NF‑κB cytokine release {1; 2}.
• Mitochondrial ROS are known to upregulate DNMT3A and promote promoter methylation in senescence models {3}.
• NAD⁺ boosters such as NR improve mitochondrial function and reduce ROS in aged tissues {4}.
• No study has directly linked mitochondrial ROS → DNMT3A → HAS2 silencing → LMW‑HA accumulation in the skin‑joint axis.

Predictions

1. In aged mouse skin and cartilage, mitochondrial ROS levels will positively correlate with DNMT3A occupancy at the HAS2 promoter and inversely with HAS2 mRNA.
2. NR supplementation will decrease mitochondrial ROS, reduce DNMT3A binding, increase HAS2 transcription, and shift HA distribution towar

Hypothesis

Age‑related decline in circulating taurine creates a substrate shortage for bile acid conjugation, prompting the ileum to upregulate ASBT (SLC10A2) to reclaim taurine‑conjugated bile acids. This compensatory increase exacerbates systemic accumulation of unconjugated primary bile acids and ammonia, fueling neuroinflammation and cognitive loss. Restoring taurine levels should normalize ileal ASBT expression, rebalance the bile acid pool, and ameliorate gut‑brain axis dysfunction.

Mechanistic Rationale

Taurine is a obligatory amide for the synthesis of taurocholic acid, the dominant conjugated bile acid in mice. When hepatic taurine falls with age Taurine depletion link, hepatocytes produce fewer tauro‑conjugates, shifting the bile acid pool toward glycine‑conjugated and unconjugated species. Unconjugated bile acids are poorer substrates for ASBT, reducing reabsorption efficiency and lowering the luminal bile acid signal that normally suppresses ASBT via FXR‑FGF19 signaling. The intestine senses diminished FXR activation and responds by increasing ASBT transcription to scavenge any remaining taurine‑conjugated molecules, a maladaptive loop that elevates circulating unconjugated bile acids and ammonia. Sex differences arise because estrogen enhances FXR activity; its decline in females further weakens FXR signaling, amplifying ASBT upregulation in older women.

Predictions & Experimental Design

1. Taurine supplementation lowers ileal ASBT – Aged female mice receiving 1% taurine in drinking wate

Hypothesis

Transient senescent cells release extracellular vesicles (EVs) enriched in SASP‑modulated microRNAs that act as niche‑support signals for resident stem cells. Premature removal of these senescent cells by senolytics depletes the EV pool, leading to impaired stem‑cell activation and delayed tissue regeneration, whereas chronic senescent cell accumulation shifts EV cargo toward pro‑inflammatory miRNAs that disrupt niche function.

Mechanistic Rationale

• Senescent cells during wound healing secrete PDGF‑Aa and other growth factors that promote myofibroblast differentiation and matrix deposition [1]. In parallel, they load exosomes with miR‑21, miR‑29b and miR‑146a, which have been shown to enhance fibroblast migration and suppress apoptosis in neighboring cells (hypothetical but supported by EV‑miRNA studies in senescence [2]).
• The SASP composition is dynamic: early SASP is rich in IGF‑binding proteins and TGF‑β isoforms that favor EV loading of regenerative miRNAs; late SASP becomes dominated by IL‑6, CXCL2 and MMPs, altering EV RNA sorting toward inflammatory miR‑155 and miR‑125b [3].
• Stem cell niches (e.g., hair follicle bulge, intestinal crypt) rely on paracrine cues that can be delivered via EVs; loss of these cues reduces stem‑cell proliferation markers (Ki‑67, Sox9) and delays re‑epithelialization [4].
• Senolytic agents (e.

Hypothesis

NFATc4 functions as a calcium‑sensitive brake on calcineurin‑driven atrophy signaling. In young muscle, RSK2‑mediated phosphorylation of NFATc4 promotes its nuclear import and stabilizes a repressive complex with HDAC3 that keeps the atrogin‑1 and MuRF1 promoters silent. With age, declining RSK2 activity (or increased phosphatase activity) reduces NFATc4 phosphorylation, shifting the equilibrium toward a de‑phosphorylated state that has lower DNA affinity and fails to recruit HDAC3. Consequently, calcineurin/NFAT signaling is no longer restrained, leading to miR‑23a loss and activation of the ubiquitin‑proteasome atrophy program. This model explains why NFATc4 knockout mice show no overt phenotype (the brake is already released in young tissue) yet predicts that restoring NFATc4 phosphorylation in aged muscle will attenuate atrophy independently of nerve activity.

Novel mechanistic reasoning

1. Phospho‑dependent co‑repressor recruitment – We propose that phosphorylated NFATc4 creates a docking site for HDAC3 via a phospho‑serine‑binding pocket, a interaction not described for other NFAT isoforms. De‑phosphorylation abolishes this contact, converting NFATc4 from a repressor to a neutral or weakly activating factor.
2. Fiber‑type specific RSK2 expression – RSK2 is enriched in fast‑twitch fibers; thus, the NFATc4 brake is stronger in tibialis anterior than soleus, matching the observed fiber‑type differences in NFATc1 nuclear localization and providing a built‑in susceptibility to atrophy in fast muscles during aging.
3. Feedback with miR‑23a – Lo

Hypothesis

Early‑phase senescent cells act as mitochondrial benefactors, exporting healthy mitochondria via tunneling nanotubes or extracellular vesicles to neighboring epithelial cells, thereby sustaining ATP production and limiting ROS‑induced apoptosis during acute injury. This beneficial exchange is driven by the p21‑mediated senescent state, which preserves SIRT6 activity and promotes a SASP enriched in mitogenic and mitoprotective factors (e.g., GDF15, miR‑21). When stress persists, p16INK4a accumulation suppresses SIRT6, shifts SASP toward pro‑inflammatory cytokines (IL‑6, TNF‑α, TGF‑β1), and reprograms the senescent secretome to package damaged mitochondria and oxidative‑stress‑inducing miRNAs (miR‑34a). Consequently, the same senescent population transitions from mitochondrial donors to recipients of damaged organelles, propagating metabolic dysfunction and fibrosis.

Mechanistic Basis

• p21‑high/sirt6‑high senescent tubular cells maintain NAD⁺ levels, deacetylate SOD2, and reduce mitochondrial ROS, creating a quality‑controlled mitochondrial pool that can be transferred via CD63⁺ exosomes [[https://pmc.ncbi.nlm.nih.gov/articles/PMC10833603/]].
• Persistent oxidative stress or TGF‑β/Notch signaling triggers p16INK4a up‑regulation, which inhibits SIRT6 transcription [[https://pmc.ncbi.nlm.nih.gov/articles/PMC11385655/]], leading to hyperacetylated SOD2, increased mtROS, and sorting of oxidized mtDNA into exosomes [[https://pmc.ncbi.nlm.nih.gov/articles/PMC6614612/]].
• Podocytes, lacking proliferative capacity, are especially dependent on exogenous mitochond

Hypothesis

In aged bone marrow, senescent stromal cells establish a spatially restricted senescence‑associated secretory phenotype (SASP) gradient that remodels CXCL12 retention and signaling, thereby displacing Cxcl12+Lepr+ skeletal stem/progenitor cells (SSPCs) from their perivascular niche and impairing hematopoietic support.

Mechanistic Rationale

• Senescent cells secrete IL‑6, TGF‑β, and MMPs that can cleave heparan sulfate proteoglycans (HSPGs) anchoring CXCL12 to the extracellular matrix, reducing its local concentration (1).
• Loss of matrix‑bound CXCL12 flattens the chemokine gradient that normally retains Pdgfra+Sca1+ SSPCs at the periosteum and Cxcl12+Lepr+ SSPCs in the marrow (2).
• Displaced SSPCs experience altered Notch and Wnt signaling, shifting them toward a fibro‑adipogenic phenotype, which further reinforces a pro‑fibrotic, immunosuppressive microenvironment.

Experimental Design

1. Sample preparation – Harvest femur/tibia from young (3 mo) and aged (24 mo) mice; include a cohort treated with a senolytic (dasatinib + quercetin) for 2 weeks.
2. Spatial transcriptomics – Apply Seq‑Scope‑X hydrogel expansion to achieve subcellular resolution; capture nuclear/cytoplasmic mRNA and generate gene‑expression matrices at ~0.5 µm voxel size.
3. Targeted markers – Quantify transcripts for senescence (Cdkn2a/p16^Ink4a, Il6, Tgfb1, Mmp9), CXCL12, Cxcr4, SSPC signa

Hypothesis

Intermittent fasting combined with a small-molecule activator of the Piwi-piRNA pathway can re-program somatic cells to execute germline-level transposon surveillance, thereby reducing age-associated genomic instability and extending healthspan.

Mechanistic Rationale

Germline immortality relies on constitutive Piwi-piRNA complexes that silence transposable elements (TEs) before they can copy and paste.[2] Somatic cells largely lack this system, allowing TE reactivation that drives inflammation, senescence and cancer.[4] Fasting activates GCN2-dependent autophagy and boosts NAD+ levels, creating a metabolic state that favors chromatin remodeling.[5] Recent work shows that nutrient stress can increase expression of PIWIL1 and PIWIL2 in cultured fibroblasts when coupled with a CR-derived metabolite, beta-hydroxybutyrate.[6] We propose that a fasting-derived ketone body, together with a small-molecule that stabilizes Piwi-protein-piRNA interactions (e.g., a benzimidazole derivative identified in a high-throughput screen[7]), will trigger de-novo piRNA biogenesis in somatic nuclei. The resulting piRNA pool will load onto Piwi proteins, guiding heterochromatin formation at active TE loci, lowering their transcription and retrotransposition.

Experimental Design

1. Animal model – C57BL/6 mice, 6 months old, split into four groups (n=15 per group): ad libitum control, intermittent fasting (IF) 24 h fast twice weekly, IF + Piwi-activator (daily low-dose oral), Piwi-activator alone.
2. Intervention length – 6 months.
3. Readouts –
   • Small-RNA sequencing of li

Evidence shows aging colons lose ZO‑1, occludin and JAM‑A, yet it remains unclear whether this loss initiates inflammaging or merely reflects it 12. We hypothesize that an age‑related increase in basal myosin light chain kinase (MLCK) activity generates sustained perijunctional contractile tension that phosphorylates occludin and remodels ZO‑1 before any measurable decline in total protein levels, thereby increasing LPS permeability and triggering systemic inflammation.

Mechanistic rationale

• With age, colonic submucosal fibrosis raises tissue stiffness, enhancing integrin α5β1‑mediated mechanotransduction to epithelial cells 3. This chronic tensile bias primes MLCK for heightened activity independent of inflammatory cytokines.
• Persistent MLCK‑driven phosphorylation of occludin at Ser408 disrupts its binding to ZO‑1, causing rapid reorganization of the perijunctional F‑actin ring and opening of paracellular pathways 4.
• Because total occludin/ZO‑1 protein synthesis remains unchanged early in this process, standard immunostaining may miss the functional deficit until prolonged phosphorylation triggers proteolytic degradation.
• The resulting rise in paracellular LPS flux engages TLR4 on lamina propria macrophages, activating NF‑κB and MAPK pathways and elevating circulating IL‑6 and TNF‑α [5](https://pmc.ncbi.nlm.nih.gov/articles/P